Waters' BioAccord liquid chromatography-mass spectrometry system will be implemented as a new bioprocess analyzer with data connectivity to Sartorius' Ambr multiparallel bioreactor systems to deliver mass spectral information on drug substances, related analytes, and cell culture media. This combination aims to shorten the biopharmaceutical process development from over a month to two days or less.

Waters, U. of Delaware to collaborate on biopharma processing
Waters and the University of Delaware have initiated a five-year collaboration focused on improving quality, yields, and efficiency in the manufacturing...

Waters introduces new LC-MS system
Lab equipment supplier Waters has introduced the BioAccord system with Acquity Premier, a liquid chromatography-mass spectrometry (LC-MS) system designed...

Waters reports Q2 earnings, cites commercial momentum
Lab equipment supplier Waters reported that its second-quarter sales rose by 31% to $682 million, up from $520 million in 2020.

Waters expands collaboration with BTI of Singapore
Waters has expanded its existing collaboration with the Bioprocessing Technology Institute (BTI), a research entity in Singapore's Agency for Science,...

Waters launches Arc Premier liquid chromatography
Lab equipment supplier Waters has unveiled the Arc Premier system, a liquid chromatography system aimed at increasing precision and certainty in chromatography...